We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Premature Babies Not Aided by NO

By HospiMedica staff writers
Posted on 01 Aug 2005
Inhaled nitric oxide therapy for lung problems in pre-term infants does not reduce the infant's chances for death or further lung problems, according to a study in the July 7, 2005, issue of The New England Journal of Medicine.

Inhaled nitric oxide is effective for treating full-term infants with lung complications. More...
In term infants, whose lungs are fully formed, these complications result from lung infection. For the treatment, nitric oxide gas is mixed with oxygen and given to an infant through a breathing apparatus. The treatment relaxes the blood vessels in the lungs, allowing the lungs to absorb oxygen more easily. Because this treatment helps infants, researchers had been interested in its possible use to treat lung complications in preterm babies.

A team of researchers with the U.S. National Institute of Child Health and Human Development (NICHD, Bethesda, MD, USA; www.nichd.nih.gov) enrolled 420 infants born at less than 34 weeks' gestation, weighing between 14 ounces to three pounds, two ounces. All infants required assisted ventilation and had a diagnosis of respiratory distress syndrome, sepsis or pneumonia, or other breathing problems. The infants were randomly assigned to receive either inhaled nitric oxide or a placebo.

The results showed no difference between the infants who received the inhaled nitric oxide and those who did not: 60% of infants who received it and 68% of those who did not developed bronchopulmonary dysplasia, a serious lung condition involving lung inflammation and scarring. Both groups had high death rates (52% in the inhaled nitric oxide group and 44% in the placebo group.)

"Contrary to our hopes as neonatologists, inhaled nitric oxide treatment did not reduce the incidence of death or further lung problems,” said co-author Dr. Rosemary Higgins, of NICHD's pregnancy and perinatology branch. "The smallest and sickest of infants were not sufficiently developed.”

The researchers found that infant weight affected the outcome among infants receiving inhaled nitric oxide. Infants in this group weighing between 1,000 and 1,500 g had a significantly lower death rate than infants in the placebo group. Infants weighing less than 1,000 grams in this group had a higher death rate than those in the placebo group. In addition, infants receiving inhaled nitric oxide through conventional mechanical ventilation had a higher mortality rate than those receiving the therapy through high-frequency ventilation.

"We have more work to do to better understand how to best help premature infants with severe lung problems,” observed Dr. Higgins.




Related Links:
NICHD

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Spirometry & Oximetry Software
MIR Spiro
Premium Air-Mattress
MA-51
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.